This comprehensive reference guide is an essential tool for developing and maintaining a clear understanding of Canada's public and private sector drug plans.
This report provides an overview of the Canadian health care system and pharmaceutical market, examines drug pricing and reimbursement procedures in detail, and concludes with a brief assessment of the outlook for the Canadian pharmaceutical market.
This report examines the potential for parallel trade between Canada and the United States and the implications for the pharmaceutical industry in both countries.
The study, an update of 1997 research, examined the cost impact to payers of several models of National Pharmacare.
This paper compares the prices of top selling generic drugs in Canada with prices for comparable generic products in the United States.
This report discusses developing pricing strategies for pharmaceuticals in today's global market covering the many complicated variables to consider.
The purpose of this study is to develop an economic analysis of the Canadian balance of trade in pharmaceuticals.
This study examines the costs and benefits of pharmaceuticals in relation to the C-91 amendments to the Patent Act.